Hyperforin inhibits cell growth by inducing intrinsic and extrinsic apoptotic pathways in hepatocellular carcinoma cells

…, YC Chen, YC Kuo, BJ Chen, MC Weng… - Anticancer …, 2017 - ar.iiarjournals.org
The aim of the present study was to investigate the antitumor effect and mechanism of action
of hyperforin in hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro. Cells were treated …

[HTML][HTML] Preparation and characterization of pH sensitive Chitosan/3-Glycidyloxypropyl Trimethoxysilane (GPTMS) hydrogels by sol-gel method

CP Li, MC Weng, SL Huang - Polymers, 2020 - mdpi.com
pH responsive chitosan and 3-Glycidyloxypropyl trimethoxysilane (GPTMS) hydrogels were
synthesized by the sol-gel crosslinking reaction. GPTMS was introduced to influence several …

[HTML][HTML] Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo

MC Weng, MH Li, JG Chung, YC Liu, JY Wu… - Biomedicine & …, 2019 - Elsevier
Non-small cell lung cancer (NSCLC) is a malignant lung cancer type with poor prognosis.
NF-κB, the oncogenic transcription factor, has been recognized as an important mediator in …

Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice

MC Weng, MH Wang, JJ Tsai, YC Kuo, YC Liu… - Bioscience …, 2018 - portlandpress.com
Regorafenib has been demonstrated in our previous study to trigger apoptosis through
suppression of extracellular signal-regulated kinase (ERK)/nuclear factor-κB (NF-κB) activation in …

Sorafenib induces apoptosis and inhibits NF-κB-mediated anti-apoptotic and metastatic potential in osteosarcoma cells

…, KH Lin, BS Fu, FT Hsu, JJ Tsai, MC Weng… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: Sorafenib, an oral multi-kinase inhibitor, has been shown to improve the
outcome of patients with osteosarcoma (OS). However, the anti-OS effect and mechanism of …

[HTML][HTML] SPECT/CT imaging for tracking subendothelial retention of electronegative low-density lipoprotein in vivo

SH Law, CC Ke, CS Chu, SH Liu, MC Weng… - International Journal of …, 2023 - Elsevier
The fifth subfraction of low-density lipoprotein (L5 LDL) can be separated from human LDL
using fast-protein liquid chromatography with an anion exchange column. L5 LDL induces …

Therapeutic efficacy and inhibitory mechanism of regorafenib combined with radiation in colorectal cancer

…, JG Chung, JH Hsieh, CH Chiang, MC Weng… - in vivo, 2020 - iv.iiarjournals.org
Background: Although both chemotherapy and radiotherapy (RT) can sufficiently maintain
tumor suppression of colorectal cancer (CRC), these treatments may trigger the expression of …

Lenvatinib induces AKT/NF-κB inactivation, apoptosis signal transduction and growth inhibition of non-small cell lung cancer in vivo

YC Liu, FT Hsu, JG Chung, MC Weng… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: Non-small cell lung cancer (NSCLC) is the most common type of lung
cancer with poor prognosis. Lenvatinib is a multi-kinase inhibitor that has the potential to …

Random and site-specific radiolabeling of [89Zr]Zr-DFO-anti-PD-L1-mAb iPET tracer

…, WL Lo, LC Chen, KT Chen, MC Weng… - … of Radioanalytical and …, 2024 - Springer
Zirconium-89 radiolabeled immuno-positron emission tomography ( 89 Zr-iPET) has become
a critical tool for patient stratification before and after immunotherapies for therapeutic …

Size effect on tumor treatment with PEGylated liposomal drugs in a tumor-bearing mouse model

YY Lin, JJ Li, MC Weng, JJ Hwang, YL Tseng, MH Lin… - 2011 - Soc Nuclear Med
1737 Objectives PEGylated liposomes are important drug carriers, which can passively
target tumor by enhanced permeability and retention effect in neoplasm lesions. This study …